ACADIA PHARMACEUTICALS INC（ACAD）内部人交易：高管与董事近期交易
过去 18 个月，共有 18 位内部人为 ACADIA PHARMACEUTICALS INC（ACAD）报告了 91 笔 Form 4 交易（最近一笔 2026-08-07）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-07 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 买入 | 5,849 | $104,346 |
| 2026-08-07 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 卖出 | 5,849 | $169,638 |
| 2026-08-07 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 买入 | 14,292 | $254,969 |
| 2026-08-07 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 卖出 | 5,000 | $145,000 |
| 2026-08-07 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 卖出 | 9,292 | $272,604 |
| 2026-07-31 | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | 买入 | 32,272 | $0 |
| 2026-07-31 | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | 卖出 | 16,508 | $431,354 |
| 2026-07-31 | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | 卖出 | 50 | $1,308 |
| 2026-06-29 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 卖出 | 11,421 | $297,860 |
| 2026-06-02 | Baker Brothers Life Sciences LP | 董事 | 买入 | 18,622 | $0 |
| 2026-06-02 | BAKER FELIX | 董事 | 买入 | 18,622 | $0 |
| 2026-06-02 | BAKER BROS. ADVISORS LP | 董事 | 买入 | 18,622 | $0 |
| 2026-06-02 | BAKER JULIAN | 董事 | 买入 | 18,622 | $0 |
| 2026-06-02 | 667, L.P. | 董事 | 买入 | 18,622 | $0 |
| 2026-06-02 | Baker Bros. Advisors (GP) LLC | 董事 | 买入 | 18,622 | $0 |
| 2026-06-02 | BAKER JULIAN | 董事 | 买入 | 18,622 | $0 |
| 2026-06-02 | BAKER FELIX | 董事 | 买入 | 18,622 | $0 |
| 2026-06-02 | BAKER BROS. ADVISORS LP | 董事 | 买入 | 18,622 | $0 |
| 2026-06-02 | Baker Brothers Life Sciences LP | 董事 | 买入 | 18,622 | $0 |
| 2026-06-02 | 667, L.P. | 董事 | 买入 | 18,622 | $0 |
| 2026-06-02 | Baker Bros. Advisors (GP) LLC | 董事 | 买入 | 18,622 | $0 |
| 2026-06-01 | Brege Laura | 董事 | 买入 | 8,107 | $0 |
| 2026-06-01 | Poole Jonathan | 董事 | 买入 | 2,010 | $0 |
| 2026-06-01 | HARRIGAN EDMUND | 董事 | 买入 | 8,107 | $0 |
| 2026-06-01 | Ndu Adora | 董事 | 买入 | 8,107 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-07